Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35

Journal of Neuroscience Research

Volumn 84, Issue 4, 2006, Pages 747-754

  Hosokawa, Tomohisa ^a   Saito, Taro ^a   Asada, Akiko ^a   Ohshima, Toshio ^b   Itakura, Makoto ^c   Takahashi, Masami ^c   Fukunaga, Kohji ^d   Hisanaga, Shin Ichi ^a  

^a TOKYO METROPOLITAN UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Ca2+ calmodulin dependent protein kinase II; Cyclin dependent kinase 5; Glutamate; Long term potentiation; N methyl D aspartate; p35

Indexed keywords

CALMODULIN; CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIN DEPENDENT KINASE 5; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; PROTEIN P35; UNCLASSIFIED DRUG; AMINO ACID RECEPTOR STIMULATING AGENT; CALMODULIN-DEPENDENT PROTEIN KINASE II; CDK5R PROTEIN, RAT; ENZYME INHIBITOR; HISTONE H1 KINASE; N METHYLASPARTIC ACID; PHOSPHOTRANSFERASE; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PURINE DERIVATIVE; ROSCOVITINE;

ANIMAL CELL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; IN VITRO STUDY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; ANIMAL; BRAIN CORTEX; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; EMBRYO; ENZYME ACTIVATION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPRECIPITATION; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CEREBRAL CORTEX; CYCLIN-DEPENDENT KINASE 5; DOWN-REGULATION; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID AGONISTS; FLUORESCENT ANTIBODY TECHNIQUE; GLUTAMIC ACID; IMMUNOPRECIPITATION; N-METHYLASPARTATE; NEURONS; PHOSPHORYLATION; PHOSPHOTRANSFERASES; PROTEIN KINASES; PURINES; RATS;

EID: 33748551425     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20975     Document Type: Article

References (35)

1. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P. 1999. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402:669-671.
2. Bibb JA, Nishi A, O'Callaghan JP, Ule J, Lan M, Snyder GL, Horiuchi A, Saito T, Hisanaga S, Czernik AJ, Nairn AC, Greengard P. 2001. Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J Biol Chem 276:14490-14497.
3. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39.
4. Brocke L, Chiang LW, Wagner PD, Schulman H. 1999. Functional implications of the subunit composition of neuronal CaM kinase II. J Biol Chem 274:22713-22722.
5. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH. 1997. Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18:29-42.
6. Colbran RJ. 2004. Protein phosphatases and calcium/calmodulin-dependent protein kinase II-dependent synaptic plasticity. J Neurosci 24:8404-8409.
7. 2+/calmodulin- kinase II enhances channel conductance of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionate type glutamate receptors. Proc Natl Acad Sci U S A 96:3269-3274.
8. Dhavan R, Tsai LH. 2001. A decade of CDK5. Nat Rev Mol Cell Biol 2:749-759.
9. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 22:7879-7891.
10. Fischer A, Sananbenesi F, Spiess J, Radulovic J. 2003. Cdk5: a novel role in learning and memory. Neurosignals 12:200-208.
11. 2+/ calmodulin-dependent protein kinase II. J Biol Chem 268:7863-7867.
12. Giese KP, Fedorov NB, Filipkowski RK, Silva AJ. 1998. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 279:870-873.
13. Hisanaga S, Saito T. 2003. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 12:221-229.
14. Humbert S, Lanier LM, Tsai LH. 2000. Synaptic localization of p39, a neuronal activator of cdk5. Neuroreport 11:2213-2216.
15. Huttner WB, Schiebler W, Greengard P, De Camilli P. 1983. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96:1374-1388.
16. Inamura M, Itakura M, Okamoto H, Hoka S, Mizoguchi A, Fukazawa Y, Shigemoto R, Yamamori S, Takahashi M. 2006. Differential localization and regulation of stargazin-like protein, gamma-8 and stargazin in the plasma membrane of hippocampal and cortical neurons. Neurosci Res 55:45-53.
17. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-364.
18. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO, Pant HC. 2001. Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci U S A 98:12742-12747.
19. Liu J, Fukunaga K, Yamamoto H, Nishi K, Miyamoto E. 1999. Differential roles of Ca(2+)/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation. J Neurosci 19:8292-8299.
20. Malinow R, Malenka RC. 2002. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126.
21. Morabito MA, Sheng M, Tsai LH. 2004. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J Neurosci 24:865-876.
22. 2+/calmodulin-dependent protein kinase II activity in cultured rat hippocampal neurons. J Neurochem 64:2132-2139.
23. Nath R, Davis M, Probert AW, Kupina NC, Ren X, Schielke GP, Wang KK. 2000. Processing of cdk5 activator p35 to its truncated form (p25) by calpain in acutely injured neuronal cells. Biochem Biophys Res Commun 274:16-21.
24. Nguyen C, Bibb JA. 2003. Cdk5 and the mystery of synaptic vesicle endocytosis. J Cell Biol 163:697-699.
25. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB. 1996. Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93:11173-11178.
26. Ohshima T, Ogura H, Tomizawa K, Hayashi K, Suzuki H, Saito T, Kamei H, Nishi A, Bibb JA, Hisanaga S, Matsui H, Mikoshiba K. 2005. Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J Neurochem 94:917-925.
27. Paglini G, Peris L, Diez-Guerra J, Quiroga S, Caceres A. 2001. The Cdk5-p35 kinase associates with the Golgi apparatus and regulates membrane traffic. EMBO Rep 2:1139-1144.
28. Saito T, Ishiguro K, Onuki R, Nagai Y, Kishimoto T, Hisanaga S. 1998. Okadaic acid-stimulated degradation of p35, an activator of CDK5, by proteasome in cultured neurons. Biochem Biophys Res Commun 252:775-778.
29. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, Larsen MR, Cousin MA, Robinson PJ. 2003. Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 5:701-710.
30. +-independent activity. Proc Natl Acad Sci U S A 85:6337-6341.
31. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li ST, Takei K, Matsui H. 2002. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 22:2590-2597.
32. Tomizawa K, Sunada S, Lu YF, Oda Y, Kinuta M, Ohshima T, Saito T, Wei FY, Matsushita M, Li ST, Tsutsui K, Hisanaga S, Mikoshiba K, Takei K, Matsui H. 2003. Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J Cell Biol 163:813-824.
33. Vanhoutte P, Bading H. 2003. Opposing roles of synaptic and extrasynaptic NMDA receptors in neuronal calcium signalling and BDNF gene regulation. Curr Opin Neurobiol 13:366-371.
34. Wei FY, Tomizawa K, Ohshima T, Asada A, Saito T, Nguyen C, Bibb JA, Ishiguro K, Kulkarni AB, Pant HC, Mikoshiba K, Matsui H, Hisanaga S. 2005. Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J Neurochem 93:502-512.
35. Yan Z, Chi P, Bibb JA, Ryan TA, Greengard P. 2002. Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J Physiol 540:761-770.